HZHong-Yu Zou

Hong-Yu Zou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hong-Yu Zou has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Bing Cao

    Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China

    1 shared publication
  • Chen-Xuan Lu

    Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China

    1 shared publication
  • Na Wang

    Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China

    1 shared publication
  • Qian-Ying Li

    Department of Laboratory Medicine, Jiulongpo District Psychiatric Health Center of Chongqing, Chongqing 401329, China

    1 shared publication
  • Yan Huang

    Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China

    1 shared publication
  • Yuan-Li Liu

    Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China

    1 shared publication

Latest Publications

  • Open Access

    Alterations of serum metabolic profile in major depressive disorder: A case-control study in the Chinese population

    by Bing Cao, Yuan-Li Liu, Na Wang, Yan Huang, Chen-Xuan Lu, Qian-Ying Li, Hong-Yu Zou

    BACKGROUND Major depressive disorder (MDD) is characterized by persistent depressed mood and cognitive symptoms. This study aimed to discover biomarkers for MDD, explore its pathological mechanisms, and examine the associations of the identified biomarkers with clinical and psychological variables. AIM To discover candidate biomarkers for MDD identification and provide insight into the pathological mechanism of MDD. METHODS The current study adopted a single-center cross-sectional case-control design. Serum samples were obtained from 100 individuals diagnosed with MDD and 97 healthy controls (HCs) aged between 18 to 60 years. Metabolomics was performed on an Ultimate 3000 UHPLC system coupled with Q-Exactive MS (Thermo Scientific). The online software Metaboanalyst 6.0 was used to process and analyze the acquired raw data of peak intensities from the instrument. RESULTS The study included 100 MDD patients and 97 HCs. Metabolomic profiling identified 35 significantly different metabolites (e.g. , cortisol, sebacic acid, and L-glutamic acid). Receiver operating characteristic curve analysis highlighted 8-HETE, 10-HDoHE, cortisol, 12-HHTrE, and 10-hydroxydecanoic acid as top diagnostic biomarkers for MDD. Significant correlations were found between metabolites (e.g. , some lipids, steroids, and amino acids) and clinical and psychological variables. CONCLUSION Our study reported metabolites (some lipids, steroids, amino acids, carnitines, and alkaloids) responsible for discriminating MDD patients and HCs. This metabolite profile may enable the development of a laboratory-based diagnostic test for MDD. The mechanisms underlying the association between psychological or clinical variables and differential metabolites deserve further exploration.